ST. PAUL, Minn.--(BUSINESS WIRE)--NxThera, Inc., a St. Paul-based, privately held medical device company that developed the Rezum™ vapor ablation system to treat a variety of endourology conditions, beginning with benign prostatic hyperplasia (BPH), today announced the appointment of André de Bruin as chair of the company’s board of directors.